Oliver III - Renalytix Chief Officer
Insider
Oliver III is Chief Officer of Renalytix AI
| Phone | 646 397 3970 |
| Web | https://renalytix.com |
Renalytix Management Efficiency
The company has return on total asset (ROA) of (0.9354) % which means that it has lost $0.9354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.7318) %, meaning that it created substantial loss on money invested by shareholders. Renalytix's management efficiency ratios could be used to measure how well Renalytix manages its routine affairs as well as how well it operates its assets and liabilities.Renalytix AI currently holds 8.54 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Renalytix AI has a current ratio of 2.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Renalytix's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Max Wygod | Forian Inc | 37 | |
| Mark Grove | Forian Inc | N/A | |
| MB CCS | Streamline Health Solutions | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
| Andrew Douglas | Forian Inc | N/A | |
| Jawad Shaikh | Streamline Health Solutions | N/A | |
| Peter Anevski | Progyny | 57 | |
| Julie Stadlbauer | Progyny | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Ben Stilwill | Streamline Health Solutions | N/A | |
| Jason Jones | Health Catalyst | N/A | |
| Donald Vick | Streamline Health Solutions | 61 | |
| Patrick Nelli | Health Catalyst | N/A | |
| Daniel Burton | Health Catalyst | 49 | |
| CPA CPA | National Research Corp | 66 | |
| Michael Vesey | Forian Inc | 62 | |
| Adam Dublin | Forian Inc | 59 | |
| Mark Livingston | Progyny | 58 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Daniel Barton | Forian Inc | 59 | |
| David Terrell | Forian Inc | N/A | |
Management Performance
| Return On Equity | -10.73 | |||
| Return On Asset | -0.94 |
Renalytix AI Leadership Team
Elected by the shareholders, the Renalytix's board of directors comprises two types of representatives: Renalytix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Renalytix. The board's role is to monitor Renalytix's management team and ensure that shareholders' interests are well served. Renalytix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Renalytix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oliver III, Chief Officer | ||
| Jean Casner, VP Officer | ||
| Baljit Singh, Head Operations | ||
| Howard Doran, Chief Officer | ||
| Salim FCA, Company Secretary | ||
| Fergus Fleming, Chief Officer | ||
| Andria ParksHerrera, VP Marketing | ||
| Joel MBA, Interim Officer | ||
| James MBA, Chief Officer |
Renalytix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Renalytix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.73 | |||
| Return On Asset | -0.94 | |||
| Operating Margin | (9.43) % | |||
| Current Valuation | 36.84 M | |||
| Shares Outstanding | 82.96 M | |||
| Shares Owned By Insiders | 4.51 % | |||
| Shares Owned By Institutions | 4.13 % | |||
| Number Of Shares Shorted | 378.92 K | |||
| Price To Book | 18.77 X | |||
| Price To Sales | 9.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Renalytix Stock
If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |